Abacus Life (ABL) said late Thursday it priced an underwritten public offering of 12.5 million common shares at $8 apiece.
The company is offering 10 million shares, with the rest to be sold by certain stockholders. It also granted underwriters a 30-day option to purchase up to an additional 1.5 million shares from the company and up to 375,000 more shares from the selling stockholders.
The offering is expected to close on Nov. 25.
Abacus said gross proceeds are expected to be about $100 million, excluding the underwriters' option to purchase additional shares.
The company plans to use the proceeds for its operations, including the purchase of life settlement policies, among other things.
免責聲明：投資有風險，本文並非投資建議，以上內容不應被視為任何金融產品的購買或出售要約、建議或邀請，作者或其他用戶的任何相關討論、評論或帖子也不應被視為此類內容。本文僅供一般參考，不考慮您的個人投資目標、財務狀況或需求。TTM對信息的準確性和完整性不承擔任何責任或保證，投資者應自行研究並在投資前尋求專業建議。